Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo

Haematologica

Volumn 94, Issue 6, 2009, Pages 857-860

  Heringer Walther, Silvia ^a   Eckert, Klaus ^b   Schumacher, Sarah Mai ^c   Uharek, Lutz ^c   Wulf Goldenberg, Annika ^b   Gembardt, Florian ^d,e   Fichtner, Iduna ^b   Schultheiss, Heinz Peter ^c   Rodgers, Kathy ^f   Walther, Thomas ^c,d,e  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF HULL   (United Kingdom)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Angiotensin; CD34; Hematopoietic stem cell

Indexed keywords

ANGIOTENSIN (1-7); ANGIOTENSIN II; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN;

ANGIOTENSIN I; ANIMALS; ANTIGENS, CD11A; ANTIGENS, CD15; ANTIGENS, CD19; ANTIGENS, CD34; BONE MARROW CELLS; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HLA-DR ANTIGENS; HUMANS; INJECTIONS, SUBCUTANEOUS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED NOD; MICE, SCID; PEPTIDE FRAGMENTS; SPLEEN; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 66749124113     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2008.000034     Document Type: Article

References (10)

1. Ferrario CM. Angiotensin I, angiotensin II and their biologically active peptides. J Hypertens 2002;20:805-807
2. Takeda H, Katagata Y, Hozumi Y, Kondo S. Effects of angiotensin II receptor signaling during skin wound healing. Am J Pathol 2004;165:1653-1662 (Pubitemid 39435164)
3. Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, et al. Angiotensin receptors. J Hypertens Suppl 1996;14:S95-103. (Pubitemid 27051083)
4. Ellefson DD, diZerega GS, Espinoza T, Roda N, Maldonado S, Rodgers KE. Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice. Cancer Chemother Pharmacol 2004;53:15-24.
5. Rodgers K, Xiong S, DiZerega GS. Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy. Cancer Chemother Pharmacol 2003;51:97-106.
6. Rodgers KE, Xiong S, diZerega GS. Accelerated recovery from irradiation injury by angiotensin peptides. Cancer Chemother Pharmacol 2002;49:403-411
7. Zambidis ET, Soon Park T, Yu W, Tam A, Levine M, Yuan X, et al. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008;112:3601-3614
8. Rodgers KE, Xiong S, Steer R, diZerega GS. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 2000;18: 287-294
9. Urao N, Okigaki M, Yamada H, Aadachi Y, Matsuno K, Matsui A, et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 2006;98:1405-1413 (Pubitemid 43948065)
10. Santhanam AV, d'Uscio LV, Peterson TE, Katusic ZS. Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells. Peptides 2008;29:1451-1455